사마귀 치료제 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00024332
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 401
Buy Now

사마귀 치료제 시장은 2021년 18억 2,954만 달러 규모였으며, 2021년부터 2028년까지 연평균 3.4% 성장할 것으로 예상됩니다.



사마귀 치료제 시장의 성장세는 인간 유두종 바이러스 감염의 유병률 및 생식기 사마귀의 재발 및 신제품 개발. 그러나 저소득 국가의 열악한 진단 시나리오는 시장 성장을 제한합니다. 사마귀는 인간 유두종 바이러스(HPV)에 의해 발생하는 피부 성장입니다. HPV에는 60가지 이상의 유형이 있으며 이들 중 일부는 피부에 사마귀를 일으키는 경향이 있습니다. 국소 치료가 최소한의 부작용으로 몇 주 안에 사마귀 문제를 해결할 수 있지만 항상 효과적이지는 않을 수 있습니다. 따라서 액체질소를 이용한 냉동요법은 완치율이 60~90%, 재발률이 10~20% 미만인 치료에 적합한 선택이다. 코로나 19. 팬데믹은 글로벌 공급망, 소비자 시장, 경제 전반에 대혼란을 일으키고 있습니다. 전 세계 정부가 시행한 조치의 결과로 사마귀 치료제 시장 성장에 부정적인 영향을 미쳤습니다.



사마귀 치료제 시장의 수익성 있는 지역

시장 통찰력 상승 인간 유두종 바이러스 감염의 보급 및 생식기 사마귀의 재발 연료 사마귀 치료제 시장 성장 사마귀는 인간 유두종 바이러스 (HPV)의 다양한 변종에 의해 발생하며 다른 변종은 신체의 다른 부분에서 사마귀를 일으 킵니다. 건강한 사람이 사마귀와 접촉하면 감염될 수 있습니다. 질병 통제 예방 센터(CDC)에 따르면 2018년 미국 인구의 ~20%, 즉 ~4,250만 명이 성병(STI)을 앓았습니다. 또한 HPV 백신 접종 전에 생식기 사마귀는 매년 미국에서 ~340,000-360,000명의 여성과 남성에게 영향을 미쳤습니다. 또한 생식기 사마귀의 재발률이 높습니다. NCBI(National Center for Biotechnology Information)에 따르면 전 세계적으로 총 사마귀 사례의 ~30%가 감염 후 첫 4개월 이내에 퇴행할 것으로 예상됩니다. 또한 HPV 감염은 자궁경부암으로 이어지며 자궁경부암은 전 세계적으로 여성에게 네 번째로 흔한 암입니다. 세계보건기구(WHO)에 따르면 2018년에 약 570,000건의 새로운 자궁경부암 사례가 저소득 국가에서 높은 유병률을 기록했습니다. 따라서 HPV 감염의 유병률 증가로 인해 사마귀 사례가 증가하고 사마귀의 높은 재발률이 사마귀 치료제 시장 성장을 주도하고 있습니다. 사마귀, 생식기 사마귀, 편평 사마귀 등. 일반적인 사마귀 부문은 시장에서 가장 큰 점유율을 차지합니다. 그러나 생식기 사마귀 세그먼트는 2021-2028년 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다. 생식기 사마귀는 일반적으로 HPV로 인해 발생하는 성병을 말합니다. 성병의 증가하는 유병률과 생식기 사마귀 치료 옵션을 개발하기 위한 연구 개발 노력의 증가는 향후 이 부문의 시장 성장을 촉진할 것입니다.



사마귀 치료제 시장, 유형별 – 2021년 및 2028년

치료 - 기반 통찰력치료를 기반으로 사마귀 치료제 시장은 물리적 파괴, 면역 조절 및 화학적 파괴로 세분화됩니다. 물리적 파괴 시장은 냉동 요법, 외과 적 제거 및 레이저 치료로 세분화됩니다. 면역 조절은 인터페론, 레티노이드 및 아연으로 세분화됩니다. 화학적 파괴 세그먼트는 블레오마이신, 칸타리딘, 살리실산 등으로 더 나뉩니다. 물리적 파괴 부문은 사마귀 치료제 시장에서 가장 큰 점유율을 차지하고 있으며 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다. 최종 사용자 기반 통찰력최종 사용자를 기준으로 사마귀 치료제 시장은 병원, 홈케어, 전문 분야로 분류됩니다. 진료소 및 기타. 병원 부문은 가장 큰 시장 점유율을 보유하고 있습니다. 그러나 홈케어 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 추정됩니다. 이 부문의 예상 시장 성장은 전 세계적으로 병원 수가 증가하고 수술 절차가 빠르게 증가하고 있기 때문일 수 있습니다. 전략적 통찰력 사마귀 치료제 시장에서 활동하는 회사는



사마귀 치료제 시장 - 유형별





  • 일반적인 사마귀

  • 생식기 사마귀

  • 편평 사마귀

  • 기타


사마귀 치료제 시장 - 치료법별





  • 물리적 파괴

      < li>냉동 요법
    • 외과적 제거

    • 레이저 치료



  • 면역 조절

    • 인터페론

    • 레티노이드

    • 아연



  • 화학적 파괴

    • 블레오마이신

    • 칸타리딘

    • 살리실산 산성

    • 기타




사마귀 치료제 시장 - 최종 사용자별





  • 병원

  • 홈케어

  • 전문 클리닉

  • 기타


지역별 사마귀 치료제 시장





  • 북미

    • 미국

    • 캐나다

    • 멕시코



  • 유럽

    • 프랑스

    • 독일

    • 이탈리아

    • 영국

    • 스페인

    • 기타 유럽



  • 아시아 태평양(APAC)

    • 중국

    • 인도

    • 대한민국

    • 일본

    • 호주

    • li>
    • 나머지 APAC



  • 중동 및 아프리카(MEA)

    • 남아프리카

    • 사우디아라비아
    • UAE

    • 나머지 MEA



  • 중남미(SCAM)

    • 브라질

    • 아르헨티나

    • 나머지 SCAM




회사 프로필





  • Bausch Health Companies Inc.

  • li>
  • Nielsen BioSciences, Inc.

  • Euro Vital Pharma GmbH

  • Cipla Inc.

  • Koninklijke Utermühlen NV

  • Novan, Inc.

  • Scholl's Wellness Company

  • TEVA PHARMACEUTICAL INDUSTRIES LTD

  • Verrica Pharmaceuticals Inc.

  • GlaxoSmithKline plc.

  • AIM ImmunoTech Inc.


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are warts therapeutics?

Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.

What are the driving factors for the Warts Therapeutics market across the globe?

The factors that are driving growth of the market are rising prevalence of human papillomavirus infections and recurrence of genital warts and new product developments.

Who are the developments carrying out by major players in the warts therapeutics market?

Various companies have made organic growth strategies in the warts therapeutics market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Nielsen BioSciences, Inc, TEVA PHARMACEUTICAL INDUSTRIES LTD amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which region is dominated the warts therapeutics market?

North America dominates the global warts therapeutics market due to factors such as rising prevalence of HPV, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

Which segment is growing at the highest CAGR in the Warts Therapeutics market?

The physical destruction segment is growing at the highest CAGR owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders.

Which region is the fastest growing in the Warts Therapeutics market?

Asia Pacific is expected to be the fastest growing region in the warts therapeutics market. The growth of the market in this region is primarily due to supportive government initiatives and research in the field of HPV infection.

The List of Companies - Warts Therapeutics Market

  1. Bausch Health Companies Inc.            
  2. Nielsen BioSciences, Inc.        
  3. Euro Vital Pharma GmbH        
  4. Cipla Inc.       
  5. Koninklijke Utermöhlen NV      
  6. Novan, Inc.    
  7. Scholl's Wellness Company    
  8. TEVA PHARMACEUTICAL INDUSTRIES LTD               
  9. Verrica Pharmaceuticals Inc.    
  10. GlaxoSmithKline plc.              
  11. AIM ImmunoTech Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports